Stopping finastride due to military service
    Finasteride/Dutasteride 11/27/2025

    Stopping finasteride and dutasteride due to military service in Egypt. Temporary hair shedding may occur, but hair should recover after resuming treatment.
    View this post in the Community →

    Similar Community Posts Join

    5 / 1000+ results

    Related Research

    6 / 1000+ results
      Endocrinology of Transgender Medicine

      research Endocrinology of Transgender Medicine

      166 citations , October 2018 in “Endocrine Reviews”
      Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research 2015

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.
      Epidemiology and Treatment of Male Androgenetic Alopecia

      research Epidemiology and Treatment of Male Androgenetic Alopecia

      January 2022 in “Journal of Healthcare Sciences”
      Male Androgenetic Alopecia, a common hair loss in men, can be slowed and partially restored with treatments like minoxidil and finasteride, or hair transplantation. Serenoa repens may be an alternative treatment. More research is needed for new treatments.
      Therapies

      research Therapies

      August 2010 in “The Journal of Dermatology”
      The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.